Goldman Sachs’s Edgewise Therapeutics EWTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.28M | Buy |
631,743
+265,099
| +72% | +$3.48M | ﹤0.01% | 2405 |
|
|
2025
Q1 | $8.07M | Buy |
366,644
+19,753
| +6% | +$435K | ﹤0.01% | 2388 |
|
|
2024
Q4 | $9.26M | Sell |
346,891
-135,334
| -28% | -$3.61M | ﹤0.01% | 2392 |
|
|
2024
Q3 | $12.9M | Sell |
482,225
-1,140,516
| -70% | -$30.4M | ﹤0.01% | 2056 |
|
|
2024
Q2 | $29.2M | Sell |
1,622,741
-125,103
| -7% | -$2.25M | ﹤0.01% | 1304 |
|
|
2024
Q1 | $31.9M | Buy |
1,747,844
+865,948
| +98% | +$15.8M | 0.01% | 1244 |
|
|
2023
Q4 | $9.65M | Sell |
881,896
-65,898
| -7% | -$721K | ﹤0.01% | 2120 |
|
|
2023
Q3 | $5.43M | Sell |
947,794
-806,055
| -46% | -$4.62M | ﹤0.01% | 2418 |
|
|
2023
Q2 | $13.6M | Buy |
1,753,849
+999,710
| +133% | +$7.75M | ﹤0.01% | 1815 |
|
|
2023
Q1 | $5.03M | Sell |
754,139
-310,982
| -29% | -$2.07M | ﹤0.01% | 2540 |
|
|
2022
Q4 | $9.52M | Buy |
1,065,121
+1,002,520
| +1,601% | +$8.96M | ﹤0.01% | 2173 |
|
|
2022
Q3 | $616K | Sell |
62,601
-83,214
| -57% | -$819K | ﹤0.01% | 4114 |
|
|
2022
Q2 | $1.16M | Buy |
145,815
+13,649
| +10% | +$109K | ﹤0.01% | 3842 |
|
|
2022
Q1 | $1.28M | Buy |
132,166
+91,654
| +226% | +$889K | ﹤0.01% | 3931 |
|
|
2021
Q4 | $619K | Buy |
+40,512
| New | +$619K | ﹤0.01% | 4379 |
|
|
2021
Q2 | – | Sell |
-65,263
| Closed | -$2.12M | – | 5408 |
|
|
2021
Q1 | $2.12M | Buy |
+65,263
| New | +$2.12M | ﹤0.01% | 3312 |
|